Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Masaru Matsuda files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd Watanabe - $5.50M of ARQT open-market activity in the last 12 months
- Howard G. Welgus - $2.18M of ARQT open-market activity in the last 12 months
- Patrick Burnett - $1.56M of ARQT open-market activity in the last 12 months
- Keith R. Leonard - $997K of ARQT open-market activity in the last 12 months
- Terrie Curran - $984K of ARQT open-market activity in the last 12 months
- Larry Todd Edwards - $968K of ARQT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Masaru Matsuda?
Masaru Matsuda is a corporate insider, tracked as Reporting Person's title: EVP, Chief Legal Officer of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Masaru Matsuda submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Masaru Matsuda been buying or selling stock?
Recorded transactions: 2 open-market purchases ($19K) and 20 open-market sales ($2.60M) across all tracked filings.
Where can I see all of Masaru Matsuda's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Masaru Matsuda and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
